Cupps Capital Management’s Gilead Sciences GILD Stock Holding History

Cupps Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-9,199	Closed	-$845K	–	176
2016 Q1	$845K	Buy	9,199 +2,555	+38%	+$230K	0.16%	138
2015 Q4	$672K	Buy	6,644 +875	+15%	+$91K	0.09%	124
2015 Q3	$566K	Sell	5,769 -16,794	-74%	-$1.87M	0.08%	128
2015 Q2	$2.64M	Buy	22,563 +12,020	+114%	+$1.31M	0.25%	104
2015 Q1	$1.03M	Sell	10,543 -5,744	-35%	-$583K	0.09%	136
2014 Q4	$1.53M	Sell	16,287 -73,771	-82%	-$7.63M	0.14%	134
2014 Q3	$9.59M	Buy	90,058 +53,764	+148%	+$5.26M	0.89%	38
2014 Q2	$3.01M	Buy	36,294 +14,633	+68%	+$1.14M	0.24%	111
2014 Q1	$1.53M	Buy	21,661 +17,831	+466%	+$1.4M	0.12%	131
2013 Q4	$287K	Buy	+3,830	New	+$267K	0.02%	136

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cupps Capital Management's GILD Position: Q2 2016 in Review

Cupps Capital Management sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 9,199 shares — an estimated $845K sold.

Cupps Capital Management first reported a position in GILD in Q4 2013 and held it in 10 quarters. The position peaked at $9.59M in Q3 2014. 1,597 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

Cupps Capital Management reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
Cupps Capital Management sold 9,199 Gilead Sciences shares in Q2 2016, an estimated $845K.
Cupps Capital Management first reported a position in Gilead Sciences in Q4 2013 and held it in 10 quarters.
Cupps Capital Management's Gilead Sciences position peaked at $9.59M in Q3 2014.
1,597 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Cupps Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.